+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma



Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma



Ophthalmic Plastic and Reconstructive Surgery 26(2): 100-102



The objective of this pilot study was to evaluate the efficacy and safety of 5% imiquimod cream in the treatment of periocular basal cell carcinoma (BCC) through the analysis of a case series. Eight subjects with primary nodular BCC of the eyelid were recruited. Treatment lasted 10 to 16 weeks. The average follow-up time was 11.7 months. Of a total of 10 lesions, 80% resolved clinically and histologically and have remained asymptomatic since. Imiquimod cream 5% was shown to be an attractive alternative to surgical treatment of periocular BCC. Future studies with larger samples and longer follow-up periods are expected to provide more accurate information on the efficacy and safety of the drug.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053693094

Download citation: RISBibTeXText

PMID: 20305508

DOI: 10.1097/iop.0b013e3181b8dd71


Related references

Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area. Orbit 33(6): 471-473, 2014

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. Bmc Ophthalmology 15: 35, 2015

Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. Journal of Ocular Pharmacology and Therapeutics 26(4): 373-379, 2010

Imiquimod 5% Cream as Pre-Treatment of Mohs Micrographic Surgery for Nodular Basal Cell Carcinoma in the Face, A Prospective Randomized Controlled Study Imiquimod As Pre-Treatment of Mohs. 2012

Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma. Skin Therapy Letter 10(6): 2-5, 2005

Treatment of Basal cell carcinoma with curettage followed by imiquimod 3.75% cream. Journal of Clinical and Aesthetic Dermatology 4(5): 39-43, 2011

Imiquimod 5% cream: a new treatment option for basal cell carcinoma. International Journal of Dermatology 41(Suppl. 1): 16-20, 2002

Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream. ActaDermato-Venereologica82(6):477, 2002

Successful Treatment of Basal Cell Carcinoma on the Face with Imiquimod 5% Cream. Acta Dermato Venereologica 82(6): 477-477, 2002

5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Archives of Dermatology 140(10): 1286-1287, 2004

Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. International Journal of Tissue Reactions 27(3): 111-114, 2005

Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. Australasian Journal of Dermatology 44(2): 123-125, 2003

The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clinical and Experimental Dermatology 28(Suppl. 1): 19-23, 2003

Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. Dermatology Nursing 21(2): 86-87, 2009

Effect on basal cell carcinoma tumor defense mechanisms after treatment with imiquimod 5% cream. Journal of Investigative Dermatology 121(1): 0959, 2003